Clinical studies with transdermal rotigotine in early Parkinson's disease.
Poewe
W
W
Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria. werner.poewe@uibk.ac.at
Luessi
F
F
D000279:Administration, Cutaneous; D000978:Antiparkinson Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D018491:Dopamine Agonists / Q000008:administration & dosage*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; C047508:rotigotine